The role of Uc160 and Uc346, which appeared to be the most promising biomarkers, was further evaluated by overexpressing these two T-UCRs in HT-29, Caco-2 and DLD-1 colon cancer cell lines. The gene discussed is RFX4-AS1; the disease is colonic neoplasm.